Trifolirhizin reduces osteoclast formation and prevents inflammatory osteolysis by inhibiting RANKL‐induced activation of NF‐κB and MAPK signaling pathways and ROS
Article in Phytotherapy Research (August 2024)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
Article in Phytotherapy Research (August 2024)
Article in Frontiers in Pharmacology (April 2024)
Article in Marine Drugs (March 2024)